Literature DB >> 7427599

Diuretic treatment of resistant hypertension.

L E Ramsay, J H Silas, S Freestone.   

Abstract

In patients with hypertension resistant to three or four drugs including a thiazide diuretic substitution of frusemide for the thiazide, or the addition of spironolactone, produced significant reductions in blood pressure and body weight. The response did not depend on the presence of overt fluid retention, renal impairment, or the use of antihypertensive drugs of high potency. Women had larger responses than men. Expansion of the plasma or extracellular fluid volume is an important cause of resistance to treatment even when a thiazide diuretic is used. An increase in diuretic treatment should be tried before using the postganglionic adrenergic blockers or minoxidil in resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427599      PMCID: PMC1714545          DOI: 10.1136/bmj.281.6248.1101

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Drugs in the management of hypertension. Part I.

Authors:  L B Page; H M Yager; J J Sidd
Journal:  Am Heart J       Date:  1976-06       Impact factor: 4.749

Review 2.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

3.  Diuretic and diet treatment of hypertension.

Authors:  H R Dustan; R C Tarazi; E L Bravo
Journal:  Arch Intern Med       Date:  1974-06

4.  Large dose furosemide therapy for hypertension. Long-term use in 22 patients.

Authors:  W J Mroczek; M Davidov; F A Finnerty
Journal:  Am J Cardiol       Date:  1974-04       Impact factor: 2.778

5.  Dependence of arterial pressure on intravascular volume in treated hypertensive patients.

Authors:  H P Dustan; R C Tarazi; E L Bravo
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

6.  Relationship of extracellular fluid volume to the development of drug resistance in the hypertensive patient.

Authors:  F A Finnerty
Journal:  Am Heart J       Date:  1971-04       Impact factor: 4.749

7.  Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics.

Authors:  O Andersson; L Hansson; R Sivertsson
Journal:  Circulation       Date:  1978-10       Impact factor: 29.690

8.  Resistant hypertension: diagnosis and management.

Authors:  R W Gifford; R C Tarazi
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

9.  Drug combinations as rational antihypertensive therapy.

Authors:  R W Gifford
Journal:  Arch Intern Med       Date:  1974-06

10.  A role of frusemide in resistant hypertension.

Authors:  M Wilson; T Morgan; A Gillies
Journal:  Med J Aust       Date:  1977-02-12       Impact factor: 7.738

View more
  12 in total

Review 1.  Treatment of resistant hypertension.

Authors:  Sandra J Taler
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

3.  Modern diuretic treatment.

Authors:  D Maclean; G R Tudhope
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-30

4.  Management of intractable hypertension.

Authors:  A Mackay
Journal:  J R Soc Med       Date:  1983-07       Impact factor: 5.344

Review 5.  Loop Diuretics in the Treatment of Hypertension.

Authors:  Line Malha; Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 6.  Individualizing antihypertensive combination therapies: clinical and hemodynamic considerations.

Authors:  Sandra J Taler
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

7.  Preliminary evaluation of pinacidil in hypertension.

Authors:  L E Ramsay; S Freestone
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

Review 8.  Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis.

Authors:  Karen Ching; Xavier Houard; Francis Berenbaum; Chunyi Wen
Journal:  Nat Rev Rheumatol       Date:  2021-07-27       Impact factor: 20.543

Review 9.  Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.

Authors:  David A Calhoun
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

Review 10.  Spironolactone: an old friend rediscovered.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.